$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pharmacotherapy for pulmonary embolism: new anticoagulants 원문보기

JKMA : Journal of the Korean Medical Association = 대한의사협회지, v.65 no.7, 2022년, pp.442 - 448  

Hwang, Hun-Gyu ,  Kim, Yang-Ki

Abstract AI-Helper 아이콘AI-Helper

Background: Pulmonary embolism is associated with reduced survival and considerable economic burden worldwide. In Korea, the incidence of pulmonary embolism has been gradually increasing. Older individuals are at an increased risk for pulmonary embolism and anticoagulation-related bleeding events. T...

참고문헌 (26)

  1. Dobromirski, Mark, Cohen, Alexander T.. How I manage venous thromboembolism risk in hospitalized medical patients. Blood, vol.120, no.8, 1562-1569.

  2. Markel, Arie. Origin and natural history of deep vein thrombosis of the legs.. Seminars in vascular medicine, vol.5, no.1, 65-74.

  3. Geerts, William H., Bergqvist, David, Pineo, Graham F., Heit, John A., Samama, Charles M., Lassen, Michael R., Colwell, Clifford W.. Prevention of Venous Thromboembolism. Chest : official publication of the American College of Chest Physicians, vol.133, no.6, 381S-453S.

  4. 10.3238/arztebl.2016.0834 

  5. Konstantinides, Stavros V., Meyer, Guy, Becattini, Cecilia, Bueno, Héctor, Geersing, Geert-Jan, Harjola, Veli-Pekka, Huisman, Menno V., Humbert, Marc, Jennings, Catriona Sian, Jiménez, David, Kucher, Nils, Lang, Irene Marthe, Lankeit, Mareike, Lorusso, Roberto, Mazzolai, Lucia, Meneveau, Nicolas, Áinle, Fionnuala Ní, Prandoni, Paolo, Pruszczyk, Piotr, Righini, Marc, Torbicki, Adam, Van Belle, Eric, Zamorano, José Luis, Galié, Nazzareno, Gibbs, J. Simon R., Aboyans, Victor, Ageno, Walter, Agewall, Stefan, Almeida, Ana G., Andreotti, Felicita, Barbato, Emanuele, Bauersachs, Johann, Baumbach, Andreas, Beygui, Farzin, Carlsen, Jørn, De Carlo, Marco, Delcroix, Marion, Delgado, Victoria, Subias, Pilar Escribano, Fitzsimons, Donna, Gaine, Sean, Goldhaber, Samuel Z., Gopalan, Deepa, Habib, Gilbert, Halvorsen, Sigrun, Jenkins, David, Katus, Hugo A., Kjellstro¨m, Barbro, Lainscak, Mitja, Lancellotti, P. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) : The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology, vol.54, no.3, 1901647-1901647.

  6. JANG, M. J., BANG, S.‐M., OH, D.. Incidence of venous thromboembolism in Korea: from the Health Insurance Review and Assessment Service database. Journal of thrombosis and haemostasis : JTH, vol.9, no.1, 85-91.

  7. Hong, Junshik, Lee, Ju Hyun, Yhim, Ho-Young, Choi, Won-Il, Bang, Soo-Mee, Lee, Heeyoung, Oh, Doyeun. Incidence of venous thromboembolism in Korea from 2009 to 2013. PloS one, vol.13, no.1, e0191897-.

  8. Hwang, Hun-Gyu, Lee, Ju Hyun, Kim, Sang-A, Kim, Yang-Ki, Yhim, Ho-Young, Hong, Junshik, Bang, Soo-Mee. Incidence of Venous Thromboembolism: The 3 rd Korean Nationwide Study. Journal of Korean medical science : JKMS, vol.37, no.17, e130-.

  9. Kearon, Clive, Akl, Elie A., Comerota, Anthony J., Prandoni, Paolo, Bounameaux, Henri, Goldhaber, Samuel Z., Nelson, Michael E., Wells, Philip S., Gould, Michael K., Dentali, Francesco, Crowther, Mark, Kahn, Susan R.. Antithrombotic Therapy for VTE Disease. Chest : official publication of the American College of Chest Physicians, vol.141, no.2, e419S-e496S.

  10. Righini, Marc, Van Es, Josien, Den Exter, Paul L, Roy, Pierre-Marie, Verschuren, Franck, Ghuysen, Alexandre, Rutschmann, Olivier T, Sanchez, Olivier, Jaffrelot, Morgan, Trinh-Duc, Albert, Le Gall, Catherine, Moustafa, Far?s, Principe, Alessandra, Van Houten, Anja A, Ten Wolde, Marije, Douma, Ren?e A, Hazelaar, Germa, Erkens, Petra M G, Van Kralingen, Klaas W, Grootenboers, Marco J J H, Durian, Marc F, Cheung, Y Whitney, Meyer, Guy, Bounameaux, Henri, Huisman, Menno V, Kamphuisen, Pieter W, Le Gal, Gr?goire. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.. JAMA : the journal of the American Medical Association, vol.311, no.11, 1117-1124.

  11. Schulman, Sam. New oral anticoagulant agents - general features and outcomes in subsets of patients. Thrombosis and haemostasis, vol.111, no.4, 575-582.

  12. Eerenberg, Elise S., Kamphuisen, Pieter W., Sijpkens, Meertien K., Meijers, Joost C., Buller, Harry R., Levi, Marcel. Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate : A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects. Circulation, vol.124, no.14, 1573-1579.

  13. Ansell, Jack, Hirsh, Jack, Hylek, Elaine, Jacobson, Alan, Crowther, Mark, Palareti, Gualtiero. Pharmacology and Management of the Vitamin K Antagonists. Chest : official publication of the American College of Chest Physicians, vol.133, no.6, 160S-198S.

  14. Song, Y., Wang, X., Perlstein, I., Wang, J., Badawy, S., Frost, C., LaCreta, F.. Relative Bioavailability of Apixaban Solution or Crushed Tablet Formulations Administered by Mouth or Nasogastric Tube in Healthy Subjects. Clinical therapeutics, vol.37, no.8, 1703-1712.

  15. Moore, Kenneth T., Krook, Mark A., Vaidyanathan, Seema, Sarich, Troy C., Damaraju, C. V., Fields, Larry E.. Rivaroxaban crushed tablet suspension characteristics and relative bioavailability in healthy adults when administered orally or via nasogastric tube. Clinical pharmacology in drug development, vol.3, no.4, 321-327.

  16. Kubitza, Dagmar, Becka, Michael, Zuehlsdorf, Michael, Mueck, Wolfgang. Effect of Food, an Antacid, and the H2 Antagonist Ranitidine on the Absorption of BAY 59-7939 (Rivaroxaban), an Oral, Direct Factor Xa Inhibitor, in Healthy Subjects. The Journal of clinical pharmacology, vol.46, no.5, 549-558.

  17. Hakeam, Hakeam A., Al-Sanea, Nasser. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs). Journal of thrombosis and thrombolysis, vol.43, no.3, 343-351.

  18. Martin, K.A., Lee, C.R., Farrell, T.M., Moll, S.. Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance. The American journal of medicine, vol.130, no.5, 517-524.

  19. Kubitza, Dagmar, Becka, Michael, Zuehlsdorf, Michael, Mueck, Wolfgang. Body Weight Has Limited Influence on the Safety, Tolerability, Pharmacokinetics, or Pharmacodynamics of Rivaroxaban (BAY 59-7939) in Healthy Subjects. The Journal of clinical pharmacology, vol.47, no.2, 218-226.

  20. Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects Upreti 908 2013 

  21. TURPIE, A. G. G., FISHER, W. D., BAUER, K. A., KWONG, L. M., IRWIN, M. W., KÄLEBO, P., MISSELWITZ, F., GENT, M.. BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. Journal of thrombosis and haemostasis : JTH, vol.3, no.11, 2479-2486.

  22. Raskob, G., Büller, H., Prins, M., Segers, A., Shi, M., Schwocho, L., van Kranen, R., Mercuri, M.. Edoxaban for the long‐term treatment of venous thromboembolism: rationale and design of the Hokusai‐venous thromboembolism study – methodological implications for clinical trials. Journal of thrombosis and haemostasis : JTH, vol.11, no.7, 1287-1294.

  23. Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism. The New England journal of medicine, vol.369, no.15, 1406-1415.

  24. Prins, Martin H, Lensing, Anthonie WA, Bauersachs, Rupert, van Bellen, Bonno, Bounameaux, Henri, Brighton, Timothy A, Cohen, Alexander T, Davidson, Bruce L, Decousus, Hervé, Raskob, Gary E, Berkowitz, Scott D, Wells, Philip S. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis journal, vol.11, 21-21.

  25. Geldhof, Vincent, Vandenbriele, Christophe, Verhamme, Peter, Vanassche, Thomas. Venous thromboembolism in the elderly: efficacy and safety of non-VKA oral anticoagulants. Thrombosis journal, vol.12, 21-21.

  26. Poli, Daniela, Antonucci, Emilia, Bertù, Lorenza, Vignini, Elisa, Ruocco, Lucia, Mastroiacovo, Daniela, Paparo, Carmelo, Pastori, Daniele, Testa, Sophie, Ageno, Walter, Palareti, Gualtiero. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study. Thrombosis research, vol.183, 28-32.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로